137 related articles for article (PubMed ID: 3514333)
1. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy.
Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
Diabetes; 1986 May; 35(5):574-8. PubMed ID: 3514333
[TBL] [Abstract][Full Text] [Related]
2. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
Retina; 1987; 7(3):170-6. PubMed ID: 3423432
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group.
Arch Ophthalmol; 1990 Sep; 108(9):1234-44. PubMed ID: 2119168
[TBL] [Abstract][Full Text] [Related]
4. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy.
Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
Arch Ophthalmol; 1985 Sep; 103(9):1307-11. PubMed ID: 2931063
[TBL] [Abstract][Full Text] [Related]
5. Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.
van Gerven JM; Boot JP; Lemkes HH; van Best JA
Doc Ophthalmol; 1994; 87(4):355-65. PubMed ID: 7851219
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
Engerman RL; Kern TS
Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy.
Pitts NE; Gundersen K; Mehta DJ; Vreeland F; Shaw GL; Peterson MJ; Collier J
Drugs; 1986; 32 Suppl 2():30-5. PubMed ID: 3098543
[TBL] [Abstract][Full Text] [Related]
8. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
Christensen JE; Varnek L; Gregersen G
Acta Neurol Scand; 1985 Feb; 71(2):164-7. PubMed ID: 3920861
[TBL] [Abstract][Full Text] [Related]
9. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
[TBL] [Abstract][Full Text] [Related]
10. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.
Cunha-Vaz JG; Gray JR; Zeimer RC; Mota MC; Ishimoto BM; Leite E
Diabetes; 1985 Jan; 34(1):53-9. PubMed ID: 3964755
[TBL] [Abstract][Full Text] [Related]
13. Early breakdown of the blood-retinal barrier in diabetes.
Cunha-Vaz J; Faria de Abreu JR; Campos AJ
Br J Ophthalmol; 1975 Nov; 59(11):649-56. PubMed ID: 1203221
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil.
O'Hare JP; Morgan MH; Alden P; Chissel S; O'Brien IA; Corrall RJ
Diabet Med; 1988 Sep; 5(6):537-42. PubMed ID: 2974776
[TBL] [Abstract][Full Text] [Related]
15. Cone electroretinograms and visual acuities of diabetic patients on sorbinil treatment.
Biersdorf WR; Malone JI; Pavan PR; Lowitt S
Doc Ophthalmol; 1988 Jul; 69(3):247-54. PubMed ID: 3168726
[TBL] [Abstract][Full Text] [Related]
16. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
Robison WG; Laver NM; Jacot JL; Glover JP
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
[TBL] [Abstract][Full Text] [Related]
17. Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes.
Cunha-Vaz JG
Diabetes; 1983 May; 32 Suppl 2():20-7. PubMed ID: 6400666
[TBL] [Abstract][Full Text] [Related]
18. Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
Engler CB; Parving HH; Mathiesen ER; Larsen M; Lund-Andersen H
Acta Ophthalmol (Copenh); 1991 Oct; 69(5):581-5. PubMed ID: 1776410
[TBL] [Abstract][Full Text] [Related]
19. Treatment of early diabetic retinopathy with cyclandelate.
Cunha-Vaz JG; Reis Fonseca J; Hagenouw JR
Br J Ophthalmol; 1977 Jun; 61(6):399-404. PubMed ID: 326306
[TBL] [Abstract][Full Text] [Related]
20. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
